Accepted Symposium submissions will be published as a supplement to the Journal of Sickle Cell Disease, published by Oxford University Press. Please note, you must submit symposium submissions to the Abstract Scorecard link in the green button below. This submission type cannot be submitted directly to the OUP website.
To have your research considered for this prestigious publication, please click the button below.
Notifications for Symposium abstracts go out February 28, 2025.
Julia Z. Xu, MD, MS is an Assistant Professor of Medicine in the Division of Classical Hematology and the Vascular Medicine Institute at the University of Pittsburgh. She specializes in the care of adults with sickle cell disease (SCD) and other red blood cell disorders. She received Bachelor’s and Master’s degrees from the University of Pennsylvania and earned her MD from Columbia University. She completed combined internal medicine-global health residency training at Duke University, where she obtained a Master of Science in Global Health and conducted research internationally as a Fogarty International Center fellow, and completed her hematology fellowship training at the NIH. Dr. Xu’s research is focused on evaluating therapies and biomarkers to address the burden of chronic anemia in SCD and working with local and international partners to improve the care of individuals living with SCD globally. She has led multiple early-phase clinical trials of novel drug therapies and combination drug therapies in patients with SCD and is investigating the potential of biomarkers of blood rheology and tissue perfusion to improve care in SCD. She is serving as the Scientific Chair of the 19th Annual Sickle Cell Disease Research and Educational Symposium and 48th National Sickle Cell Disease Scientific Meeting.
Dr. Santosh L. Saraf received his medical degree from the Temple University School of Medicine and completed an internal medicine residency and hematology & oncology fellowship at the University of Illinois at Chicago (UIC). Dr. Saraf joined the Division of Hematology & Oncology at UIC in 2012 and completed a Master of Science in Clinical and Translational Research through the University of Illinois School of Public Health in 2014. He currently serves as the Director of Translational Research for the Sickle Cell Center and the Fellowship Program Director for Hematology & Oncology. Dr. Saraf focuses his clinical care and research on understanding the mechanisms of kidney disease in patients with sickle cell disease and on developing curative therapies through hematopoietic stem cell transplantation for patients with clinically aggressive sickle cell disease.
Dr. Cheedy Jaja is an Associate Professor of Nursing. His interest in social justice, health disparities, and improving health outcomes in historically marginalized and vulnerable populations such as those with sickle cell disease drives his global health research, clinical, and advocacy initiatives in the USA and Africa. He is one of only a few nurse scientists prepared to use pharmacogenetics strategies in pharmacotherapy for sickle cell disease with a focus on developing tailored pharmacogenetics algorithms that optimize drug selection, dosing, and monitoring strategies for sickle cell disease pain. He has received national recognition for his research contributions as evidenced by being selected as a 2016 NIH Future Research Leader, a 2018 Fulbright Program Scholar, and a Fellow of the American Academy of Nursing in 2020.
